Jitsubo

Jitsubo CO., LTD. is a Japanese biotechnology company specializing in the research, development, and contract manufacturing of peptide-based active pharmaceutical ingredients using its proprietary Molecular Hiving technology — a tag-assisted liquid-phase peptide synthesis method developed with Tokyo University of Agriculture and Technology. Founded in 2005 and headquartered in Japan, Jitsubo provides peptide synthesis services ranging from sample quantities to investigational drug scale, and has established exclusive manufacturing partnerships with global pharmaceutical companies including Novo Nordisk for diabetes and obesity therapeutic areas. The company's environmentally friendly and cost-effective approach makes it a leading innovator in next-generation peptide manufacturing.